Co-delivery of pirfenidone and siRNA in ZIF-based nanoparticles for dual inhibition of hepatic stellate cell activation in liver fibrotic therapy
Kaili Wang, Hao Chen, Si Qin, Shu‐Hui Chen, Qian Zhang, Jiali Chen, Donghua Di, Guangyue Su, Yue Yuan
Topics & Concepts
PirfenidoneHepatic stellate cellIn vivoChemistryDrug deliveryCirrhosisCancer researchFibrosisPharmacologyMedicineBiologyPathologyInternal medicineBiotechnologyLungOrganic chemistryIdiopathic pulmonary fibrosisLiver physiology and pathologyOrgan Transplantation Techniques and OutcomesLiver Disease Diagnosis and Treatment